Background: Most large prospective studies of diabetes and mortality have focused on
Diabetes is increasingly common in many countries 1, 2 and increases mortality from a wide range of diseases. 3 However, most large studies of diabetes have been in high-income countries with reasonably good medical care and glycemic control. In a recent meta-analysis of 97 prospective studies, mainly from such countries, self-reported diabetes less than doubled all-cause mortality rates. 3, 4 In middle-income and low-income countries, however, where resources to manage diabetes may be more limited and vascular-protective treatments under-utilized, 5 the effects of diabetes on mortality from other diseases could be substantially larger, and in many such countries diabetes prevalence has increased substantially in recent years. 1, 2 Mexico is a middle-income country 6 with among the highest prevalence of obesity and diabetes in the world, 1, 7 and, among persons with diabetes, glycemic control is often poor 8 and not combined with treatment to control other risk factors (e.g., elevated blood pressure and hypercholesterolemia). Here we report the findings from a prospective study of the impact of diabetes on cause-specific mortality in 150,000 Mexican adults followed for 12 years.
METHODS

Recruitment
From 1998-2004, we visited households within two districts of Mexico City, inviting all residents aged ≥35 years to participate in a prospective study. 9 We recorded age, sex, socioeconomic status, lifestyle factors (e.g., alcohol intake, smoking, physical activity), current medication, and medical history (including previously diagnosed diabetes). Height, weight, waist/hip circumference, and seated blood pressure were measured. 10mL of blood was taken, transported at 4-10˚C in insulated boxes containing ice packs, refrigerated at 4˚C Part I of the certificate), they selected an appropriate underlying cause other than diabetes.
Statistical Analyses
The main analyses defined diabetes as self-reported previous medical diagnosis of diabetes and/or use of anti-diabetic medication. Sensitivity analyses included in the diabetes definition persons without this evidence, but with baseline HbA1c≥6.5. We considered those with diagnosis of diabetes before age 35 years who were taking insulin at recruitment as likely to have had type 1 diabetes.
Cox regression analysis related diabetes at recruitment to mortality, excluding people with other chronic diseases ( Fig. 1 footnotes) ). Most age-specific analyses averaged male and female RRs (which were generally similar).
Mortality rates among study participants may differ substantially from those among other
Mexicans. In extrapolating to Mexico as a whole, therefore, we estimated absolute diseasespecific mortality rates for those with and without diabetes by applying our disease-specific
RRs to the 2012 Mexican national death rates. 14 Defining premature mortality as death before age 75, we used these age-and sex-specific mortality rates to calculate the average mortality rate (for men and women combined) at ages 35-74, and then subdivided this in proportion to the underlying causes of death in our study to estimate 2012 national diseasespecific death rates. For each disease, we used the RR at ages 35-74 to calculate the average mortality rate among the proportions p with and (1-p) without diabetes as RR×A and A, such that (p×RR×A)+(1-p)×A equalled the estimated disease-specific national mortality rate. Analyses used SAS v9.3 and R v2.11.1.
RESULTS
Recruitment
Of 112,333 eligible households visited, 106,059 (94%) took part, yielding 159,755
participants. Of these potential participants, 8135 had a history of ischemic heart disease, stroke, cancer, cirrhosis, chronic obstructive pulmonary disease or chronic kidney disease (CKD), and were excluded, while a further 5574 participants were excluded because of missing data or age ≥85 years at recruitment. Table 1 shows characteristics at recruitment of the remaining 146,046 participants.
Self-reported Diabetes and HbA1c at Recruitment
The prevalence of previously diagnosed diabetes increased steeply from 3% at ages [35] [36] [37] [38] [39] to >20% in both sexes by age 60 years ( Fig. 1) . At ages 35-59, 60-74, and 75-84, the mean (SD) time since diabetes diagnosis was, respectively, 7 (6), 10 (7) and 13 (8) There was little difference in body-mass index (BMI, weight in kilograms divided by the square of height in meters) between those with and without previously diagnosed diabetes (Table 1) . However, among those without diabetes BMI at recruitment was strongly predictive of incident diabetes during follow-up, as indicated by its strong relationship with diabetes prevalence in a subset of survivors resurveyed in 2015 (Supplementary Appendix, Fig. S1 ).
Diabetes and All-cause Mortality
During about 12 years of follow-up, there were 9674 deaths from all causes at ages years in participants with no known disease (other than diabetes) before recruitment. Figure 7 and without diagnosed diabetes. These RRs were similar for men and women, and averaged 5.4 (95% CI, 5.0-6.0) at ages 35-59, 3.1 (2.9-3.3) at ages 60-74 and 1.9 (1.8-2.1) at ages 75-84 years. The age-specific RRs were similar in the two study districts (data not shown).
The excess number of deaths before age 75 associated with diabetes diagnosed before recruitment is shown in Table 2 . Even though previously diagnosed diabetes is a crude exposure measure, and misses any effects of diabetes onset during follow-up, it still accounted for 30% of all deaths. Extending the diabetes definition to include all participants with HbA1c≥6.5 at recruitment increased the proportion to 35% (Supplementary Appendix Table S1 ). Apart from diabetic crises and renal disease, the conditions associated with the greatest relative risk were cardiac disease, cerebrovascular and other vascular diseases, and infections. All involved similar age-specific RRs, which were more extreme at younger ages (and virtually identical for men and women: data not shown).
Diabetes and Disease-specific Mortality
Diabetes was also strongly associated with mortality from peptic ulcer disease, but not with mortality from cirrhosis (much of which was alcoholic). There was little association between diabetes and death from chronic obstructive pulmonary disease, from cancer as a whole (RR=1.01, 0.88-1.15), or from particular types of cancer (Supplementary Appendix Fig. S6 ), although there were too few cancer deaths for this to be a reliably null finding.
Overall, the excess mortality associated with diabetes accounted for about one-third of all vascular deaths and one-third of all other deaths. The mortality analyses were not materially affected when repeated without adjustment for smoking, education and anthropometry; with additional adjustment for alcohol, physical activity and blood pressure; with inclusion of those with prior disease or exclusion of the first 5 years of follow-up (data not shown); or by using for disease-specific outcome death with any mention of the disease of interest on Part I of the certificate (Supplementary Appendix Fig. S8 ). Figure 3 (absolute risks) combines the proportions dying at ages 35-74 from particular diseases in the current study, the disease-specific RRs at ages 35-74, and 2012 Mexican national mortality rates (see Methods). Between ages 35-74, the absolute excess mortality associated with diabetes was greatest for renal disease, followed by cardiac disease, infection, acute glycaemic crises, and the aggregate of all other vascular diseases.
Estimates of Absolute Excess Mortality
DISCUSSION
In this middle-income country, diabetes was more common, 15 and had a much larger impact on mortality, than in major high-income countries. 3, 4, 16 By ages 60-74 years about onequarter of the participants in the present study had received a medical diagnosis of diabetes (compared with about 7% in the UK 17 and 15% in the US during a similar time period 15 ), and, even after adjustment for other risk factors, the all-cause mortality rate at ages 35-74 years was approximately quadrupled among participants with such a diagnosis. In contrast, recent meta-analyses of prospective studies from mostly high-income countries showed less than a doubling in the all-cause mortality rate for those with diabetes. 3 A likely explanation for our more marked all-cause mortality RRs is inadequate medical care, including poor glycemic control. 18, 19 Over one-third of participants with diabetes diagnosed before recruitment had a baseline HbA1c>10.0 (86 mmol/mol) as compared with only about 5% of people with diagnosed diabetes in high-income country cohorts. 3, 16, 20 Further, 8% of all deaths of those with diabetes in the present study were due to acute diabetic crises, compared with <1% in the US. 21 In contrast to previous studies, 3 our all-cause mortality RRs were similar in both sexes, reflecting similar glycemic control and diabetes duration (Table   1) .
A key feature of our study is clinician review of death certificates, which had detailed, previously validated, 22 information recorded on them. WHO coding rules attribute to diabetes all vascular and renal deaths in persons with diabetes recorded in Part I of the certificate. 13 This results in undercounting of vascular and renal deaths among people with diabetes, which biases downwards the RRs that associate diabetes with these diseases. In the present work we labeled diabetes the underlying cause only for deaths that occurred during acute diabetic crises, yielding large RRs for vascular and, particularly, renal mortality. Our coding conventions do not, however, affect the RRs for overall mortality, which are also large.
Our study has certain limitations. It is not representative of Mexico as a whole. Response rates were high, however, so the study should be reasonably representative of the adults contacted at home (two-thirds female) in the two study districts. Moreover, our baseline estimates of diabetes prevalence are similar to those obtained by a large national survey in
Mexico carried out around the same time. 23 Subsequent nationally representative 2006 and importantly, glycemic control among those with diagnosed diabetes in those surveys was, if
anything, worse than in our study, 8 so our estimates of the importance of diabetes to mortality in Mexico as a whole may if anything be slightly low. As in many prospective studies, 3 we did not check self-reports of medically-diagnosed diabetes against medical records, but the HbA1c findings (and high RRs for overall mortality) suggest that such reports were reasonably reliable, with generally normal HbA1c levels in those reporting no diabetes. Sensitivity analyses that redefined diabetes to include any and all participants with HbA1c≥6.5 at baseline increased the mortality attributed to diabetes from 30% to 35%, while further inclusion of deaths due to the effects of diabetes with onset after recruitment would increase this still further (perhaps to about 40%; for example 14% of the deaths from acute diabetic crises were of people without previously diagnosed diabetes and baseline HbA1c <6.5). We cannot, however, rule out some residual confounding.
The greatest absolute excess mortality associated with diabetes was from renal disease (mainly CKD), cardiovascular disease, infection, acute diabetic crises, and stroke. Assuming causality, about three-quarters of the mortality at ages 35-74 years among Mexicans with diabetes is due (directly or indirectly) to their diabetes. Age-specific mortality rates correlated with diabetes duration (data not shown), so the lifetime hazard would be even greater for people who develop diabetes in early rather than later adult life. Overall, we estimated diabetes to be a direct or indirect cause of at least one-third of all mortality at ages 35-74 years in our study, double recent indirect estimates for Mexico that relied on RRs from other countries. 1, 24 In addition to their relevance to Mexico, our results are relevant to many other populations worldwide, including many millions of US Mexican-Americans, who have twice the US non-Hispanic white prevalence of diabetes 15 and worse glycemic control. 20 In Mexico, the aggregate of vascular, diabetic and renal mortality rates at ages 35- The high mortality from diabetes in this overweight middle-income country reflected both the high prevalence of diabetes, partly due to widespread obesity affecting diabetes incidence, and its poor prognosis, partly due to inadequate treatment of diabetes, associated risk factors, 8 and diabetic complications. Poor glycemic control increases the risk of microvascular disease, 27 but during the period of our study, regular testing for albuminuria was rare 8 and renal replacement therapy was limited. Thus, persons with CKD often had poor outcomes. 28 Mexico recently introduced its National Strategy for Overweight, Obesity and Diabetes, including health education, improved exercise opportunities, taxation of sugary drinks and high-calorie foods, and earlier identification and monitoring of risk factors, including diabetes. 29 Within a year of the introduction of this new National Strategy, preliminary data suggested that the consumption of sugary drinks had diminished. 30 However, despite whatever is achieved in the next few decades by lifestyle interventions (e.g., on adiposity, exercise, and smoking), 29, 30 many people in Mexico will still develop diabetes and require treatment to reduce their risk of premature death.
Healthcare delivery can target both diabetes itself and other determinants of the risk of death or disability from the many different diseases that diabetes can cause. 27, 33, 34, 35 In this middleincome country with a high prevalence of overweight individuals with insufficient control of blood glucose, blood pressure and cholesterol, diabetes was a cause of at least one-third of all deaths at ages 35-74 years (twice current indirect estimates for Mexico), 1,24 due chiefly to mortality from renal disease, vascular disease, infection, and acute diabetic crises.
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